Stay updated on Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.

Latest updates to the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a dedicated Locations section and explicitly listed Ohio as a study site; removed the older Ohio Locations item and the HHS Vulnerability Disclosure link, and updated the revision to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1 on the ClinicalTrials.gov page for NCT03333746. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedRemoved the government funding status notice that warned about potential updates and operational delays. The page no longer displays this funding-related banner.SummaryDifference0.4%

- Check82 days agoChange DetectedThe study record content appears unchanged apart from formatting/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check111 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

Stay in the know with updates to Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.